“showed a trend”

28 , 29 While ATG clearly decreased the risk of acute GvHD, the adjusted model showed a trend towards improved overall survival in patients who received ATG ( P =0.05).

Patients with Stage T1 tumors showed a trend toward longer survival with high SMPD3 expression level ( p = 0.05), although it was of borderline statistical significance.

However, anti-EA IgM ( Figure 5D ), and anti-EBNA6 IgM ( Figure 5E ) showed a trend to react differently in ME/CFS samples versus BD control samples ( p > 0.05, Fisher exact test) but did not reach statistical significance.

Notably, the Nrf2/HO-1 expression levels showed a trend toward upregulation in the SCI group compared with the Sham group (P>0.05), suggesting a possible endogenous compensatory response to injury-associated oxidative stress.

There was also no significant difference in cancer-directed surgery, and radiation between both groups (p>0.05), though bisphosphonate users showed a trend towards less chemotherapy use (bisphosphonate users 40.57% vs 43.51%, p=0.05).

Overweight patients showed a trend towards elevated risks of disease recurrence and death; such risks were significantly increased in obese patients (P < 0.05).

100 mg/kg PPMO-treated mice), while lower (30 mg/kg) and intermittent doses (50 mg/kg) showed a trend toward improved strength ( p < 0.05, WT and untreated mdx vs. lower and intermittent dose PPMO-treated mdx mice) ( Figure 6 A).

No significant difference in mortality was observed across RACHS-1 categories, although patients in high-risk categories (RACHS ≥4) showed a trend toward increased mortality (72% vs . 59%, p>0.05).

Even though all frontal face patches also showed a trend of within-category selectivity for monkey objects, especially for the button image, this was only significant in face patch POa ( p < 0.05).

Furthermore, a combination of the TNM staging system and ACCI showed a trend toward higher prognostic value and higher AUC for OS and CSS than the TNM staging system alone (P < 0.05).

90%; p < 0.05; OR = 2.32; 1.34–4.03; p < 0.05) (Table 3b ) and showed a trend toward higher effectiveness with Triple‐AL (92.5% vs. 86%; p ≈0.05).

Notably, following acute L-DOPA, 6-OHDA iMSN-D2RKO mice showed a trend toward increased of c-Fos + cells and of pERK 42/44 intensity/cell as compared to equally treated 6-OHDA WT (p > 0.05; Figures S5 A–S5C).

WKY rats showed a trend toward an impairment at 11–15 s ( p = 0.05).

The sensitivity analysis revealed that the change in the SF-36 mental score between admission and discharge from neurological inpatient rehabilitation was a significant ( p = 0.004) predictor of the EQ-5D dimension “mobility” 2.5 years after discharge and showed a trend towards predicting “usual activities” ( p = 0.05).

Four metabolites showed a trend toward overabundance in LAM samples (Mann–Whitney test; P < 0.05) and were subsequently analyzed in plasma from an additional set of 30 LAM patients (Appendix Table S2 ), 12 healthy age‐matched female controls, as well as samples from women with LAM‐related pulmonary diseases, the latter group comprising 10 individuals diagnosed with Langerhans cell histiocytosis, 10 with Sjögren syndrome, seven with emphysema, and three with systemic lupus erythematosus.

Vice versa, after 8 weeks, cardiac masses, volumes, and output showed a trend for lower values in sham operated rats compared to controls in absolute measures (782.2±57.2/260.2±33.2 vs. 805.9±84.8/310.4±48.5 mg, p<0.05 for left/right ventricular mass), but not normalized to body weight.

In terms of immunoregulatory effects, OVA sensitization and PM 2.5 exposure significantly increased total serum IgG ( Figure 3 A, p < 0.05) and showed a trend toward increased IgG1 levels ( Figure 3 B, p > 0.05) in the NC group compared to the Ctrl group.

BDI subscale C showed a trend toward a shorter decrease in the WNS 2.4 g group than that in the placebo group ( p < 0.05) ( Figure 4 ).

IRF showed a clear correlation with EZ thinning in the central 1 mm (p = 0.01), which was not statistically significant in the central 6 mm, but still showed a trend towards a thinning effect ( p = 0.05).

Patients with a primary site in the small intestine showed a trend toward T3–T4 (42.2%), whereas primary sites in the colorectum had a higher proportion of T1–T2 (40.0%, p = 0.050).

Moreover, for illustrative purposes, we highlighted that “travelling” showed a trend in the same direction, namely, subjects had more dreams including travelling during post‐lockdown compared with lockdown ( F 1,58 = 3.91, p = 0.05, η 2 = 0.063; Figure 3 ). 4 DISCUSSION To the best of our knowledge, the current study provided the first within‐subjects longitudinal assessment of dream activity across the pandemic in Italy.

KO sham), Wnt2 showed a trend of increase in infarct at week 8 ( p < 0.05 in KO infarct vs.

In direct comparisons between the active treatment groups, combined therapy showed a trend toward lower mortality compared with aspirin monotherapy at 28 days (HR 0.52, 95% CI: 0.27-1.00, P = 0.05), with significant benefit at 90 days (HR: 0.47, 95% CI: 0.27-0.83, P < 0.01) and 1 year (HR: 0.59, 95% CI: 0.39-0.91, P = 0.02).

Global longitudinal strain Global longitudinal strain measured by FT showed a trend towards being higher than that measured by fast‐SENC ( P value = 0.05), while fast‐SENC‐derived GLS was significantly higher than TAG ( Figure 1 and Table 1 ).

The proprioceptive acuity showed a trend of decline to 3.08 ± 2.07° in dorsiflexion and to −2.59 ± 1.94° in plantar flexion ( p > 0.05).